SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (6619)5/10/1999 8:03:00 PM
From: Linda Kaplan  Read Replies (2) of 7041
 
I noticed that SGP price wasn't effected by the news, concluded as you did, that the Street wasn't expecting a big difference in SGP's bottom line based on Vasomax. Given they're so big, well, I dunno. They made that weird speech in England claiming they expected huge sales, but I guess no one expected it would make a dent for them. ZONA's a one trick pony, though. No Vasomax, no nuthin'.

Despite Joe's remarks suggesting otherwise, I don't think that Vasomax will do much for women.

Linda
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext